Oncology drug developer Chordia Therapeutics has raised series A funding from backers including Kyoto University Innovation Capital.

Oncology drug developer Chordia Therapeutics has raised series A funding from backers including Takeda, from which it is licensing its preclinical drugs.

Danone Manifesto Ventures has invested in bottled ocean water brand Kona Deep in its fifth deal since launching in September last year.

An affiliate of USAA has contributed to a series A round that took water monitoring startup Flo Technologies' total equity funding to more than $11m.

Step Pharma, a developer of treatments for autoimmune diseases, has completed its series A round after closing a second tranche.

Bloomberg Beta has reinvested in log management software developer Scalyr, having previously backed its 2015 seed round.

The video creation marketplace will use the cash from the Stampede Ventures-backed round to expand its team across its four offices.

The ocular device spinout hopes to rapidly develop portable devices for eye testing powered by artificial intelligence software.